Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects

ConclusionThe concentration of bismuth in the blood of healthy subjects in the T formulation was not greater than that in the R formulation. Similarly, the safety of oral administration of 120 mg of bismuth potassium citrate formulations to healthy subjects was good. The trial registration number (TRN) was [2018] 013, 6 December 2018.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research